Elena Arbelo, Suleman Aktaa1, Andreas Bollmann2, André D'Avila3, Inga Drossart4, Jeremy Dwight5, Mellanie True Hills6, Gerhard Hindricks2, Fred M Kusumoto7, Deirdre A Lane8, Dennis H Lau9, Maddalena Lettino10, Gregory Y H Lip8, Trudie Lobban11, Hui-Nam Pak12, Tatjana Potpara13, Luis C Saenz14, Isabelle C Van Gelder15, Paul Varosy16, Chris P Gale1, Nikolaos Dagres2, Serge Boveda17, Thomas Deneke18, Pascal Defaye19, Giulio Conte20, Radoslaw Lenarczyk21, Rui Providencia22, Jose M Guerra23, Yoshihide Takahashi24, Cristiano Pisani25, Santiago Nava26, Andrea Sarkozy27, Taya V Glotzer28, Mario Martins Oliveira29. 1. Leeds Institute for Data Analytics, University of Leeds, UK; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, UK. 2. Department of Electrophysiology, Heart Centre Leipzig at University of Leipzig, Leipzig, Germany. 3. Cardiac Arrhythmia Service, Hospital SOS Cardio, Florianopolis, SC, Brazil; Harvard-Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. 4. European Society of Cardiology, Sophia Antipolis, France; ESC Patient Forum, Sophia Antipolis, France. 5. ESC Patient Forum, Sophia Antipolis, France. 6. StopAfib.org, American Foundation for Women's Health, Decatur, TX, USA. 7. Cardiology Department, Mayo Clinic Hospital, Jacksonville, FL, USA. 8. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. 9. Centre for Heart Rhythm Disorders, The University of Adelaide and Department of Cardiology, Royal Adelaide Hospital, Adelaide, South Australia, Australia. 10. Cardiovascular Department, San Gerardo Hospital, ASST-Monza, Monza, Italy. 11. Arrhythmia Alliance/AF Association/STARS, Chipping Norton, UK. 12. Yonsei University Health System, Seoul, Republic of Korea. 13. School of Medicine, University of Belgrade, Serbia; Cardiology Clinic, Clinical Centre of Serbia, Belgrade, Serbia. 14. Fundación Cardio Infantil-Instituto de Cardiología, Bogotá, Colombia. 15. Department of Cardiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands. 16. Rocky Mountain Regional Veterans Affairs Medical Center and the University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 17. Clinique Pasteur, Heart Rhythm Department, 31076 Toulouse, France. 18. Clinic for Interventional Electrophysiology, Heart Centre RHÖN-KLINIKUM Campus Bad Neustadt, Germany. 19. CHU Grenoble Alpes, Unite de Rythmologie Service De Cardiologie, CS10135, 38043 Grenoble Cedex 09, France. 20. Cardiology Department, Cardiocentro Ticino, Lugano, Switzerland. 21. First Department of Cardiology and Angiology, Silesian Centre for Heart Disease, Curie-Sklodowskiej Str 9, 41-800 Zabrze, Poland. 22. St Bartholomew's Hospital, Barts Heart Centre, Barts Health NHS Trust, London, UK and Institute of Health Informatics, University College of London, London, UK. 23. Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Universidad Autonoma de Barcelona, CIBERCV, Barcelona, Spain. 24. Department of Advanced Arrhythmia Research, Tokyo Medical and Dental University, Tokyo, Japan. 25. Heart Institute, Arrhythmia Unit, Sao Paulo, Brazil. 26. Head of Electrocardiology Department, Instituto Nacional de Cardiologia 'Ignacio Chavez', Mexico. 27. University Hospital of Antwerp, University of Antwerp, Antwerp, Belgium. 28. Hackensack Meridian-Seton Hall School of Medicine, Rutgers New Jersey Medical School; Director of Cardiac Research, Hackensack University Medical Center, Hackensack, USA. 29. Hospital Santa Marta, Department of Cardiology, Rua Santa Marta, 1167-024 Lisbon, Portugal.
Abstract
AIMS: To develop quality indicators (QIs) that may be used to evaluate the quality of care and outcomes for adults with atrial fibrillation (AF). METHODS AND RESULTS: We followed the ESC methodology for QI development. This methodology involved (i) the identification of the domains of AF care for the diagnosis and management of AF (by a group of experts including members of the ESC Clinical Practice Guidelines Task Force for AF); (ii) the construction of candidate QIs (including a systematic review of the literature); and (iii) the selection of the final set of QIs (using a modified Delphi method). Six domains of care for the diagnosis and management of AF were identified: (i) Patient assessment (baseline and follow-up), (ii) Anticoagulation therapy, (iii) Rate control strategy, (iv) Rhythm control strategy, (v) Risk factor management, and (vi) Outcomes measures, including patient-reported outcome measures (PROMs). In total, 17 main and 17 secondary QIs, which covered all six domains of care for the diagnosis and management of AF, were selected. The outcome domain included measures on the consequences and treatment of AF, as well as PROMs. CONCLUSION: This document defines six domains of AF care (patient assessment, anticoagulation, rate control, rhythm control, risk factor management, and outcomes), and provides 17 main and 17 secondary QIs for the diagnosis and management of AF. It is anticipated that implementation of these QIs will improve the quality of AF care. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: To develop quality indicators (QIs) that may be used to evaluate the quality of care and outcomes for adults with atrial fibrillation (AF). METHODS AND RESULTS: We followed the ESC methodology for QI development. This methodology involved (i) the identification of the domains of AF care for the diagnosis and management of AF (by a group of experts including members of the ESC Clinical Practice Guidelines Task Force for AF); (ii) the construction of candidate QIs (including a systematic review of the literature); and (iii) the selection of the final set of QIs (using a modified Delphi method). Six domains of care for the diagnosis and management of AF were identified: (i) Patient assessment (baseline and follow-up), (ii) Anticoagulation therapy, (iii) Rate control strategy, (iv) Rhythm control strategy, (v) Risk factor management, and (vi) Outcomes measures, including patient-reported outcome measures (PROMs). In total, 17 main and 17 secondary QIs, which covered all six domains of care for the diagnosis and management of AF, were selected. The outcome domain included measures on the consequences and treatment of AF, as well as PROMs. CONCLUSION: This document defines six domains of AF care (patient assessment, anticoagulation, rate control, rhythm control, risk factor management, and outcomes), and provides 17 main and 17 secondary QIs for the diagnosis and management of AF. It is anticipated that implementation of these QIs will improve the quality of AF care. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Mina K Chung; Angela Fagerlin; Paul J Wang; Tinuola B Ajayi; Larry A Allen; Tina Baykaner; Emelia J Benjamin; Megan Branda; Kerri L Cavanaugh; Lin Y Chen; George H Crossley; Rebecca K Delaney; Lee L Eckhardt; Kathleen L Grady; Ian G Hargraves; Mellanie True Hills; Matthew M Kalscheur; Daniel B Kramer; Marleen Kunneman; Rachel Lampert; Aisha T Langford; Krystina B Lewis; Ying Lu; John M Mandrola; Kathryn Martinez; Daniel D Matlock; Sarah R McCarthy; Victor M Montori; Peter A Noseworthy; Kate M Orland; Elissa Ozanne; Rod Passman; Krishna Pundi; Dan M Roden; Elizabeth V Saarel; Monika M Schmidt; Samuel F Sears; Dawn Stacey; Randall S Stafford; Benjamin A Steinberg; Sojin Youn Wass; Jennifer M Wright Journal: Circ Arrhythm Electrophysiol Date: 2021-12-06
Authors: Suleman Aktaa; Amr Abdin; Elena Arbelo; Haran Burri; Kevin Vernooy; Carina Blomström-Lundqvist; Giuseppe Boriani; Pascal Defaye; Jean-Claude Deharo; Inga Drossart; Dan Foldager; Michael R Gold; Jens Brock Johansen; Francisco Leyva; Cecilia Linde; Yoav Michowitz; Mads Brix Kronborg; David Slotwiner; Torkel Steen; José Maria Tolosana; Stylianos Tzeis; Niraj Varma; Michael Glikson; Jens Cosedis Nielsen; Chris P Gale Journal: Europace Date: 2022-01-04 Impact factor: 5.214